News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Yakup Ergün/obdh.com.tr
May 9, 2025, 09:39

Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X:

“ESMO Breast 2025 is in 5 Days!

One of the key upcoming presentations:

EMBER-3 Subgroup Analysis

  • Imlunestrant + abema improved PFS after CDK4/6i (vs. Imlu)
  • No abema benefit after abema
  • Efficacy observed after palbo and ribo
  • Consistent benefit in ESR1+ and PI3K-mutant patients.”

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared this post, adding:

“Careful about drawing conclusions on abema after abema based on 23 patients. The HR confidence intervals are incredibly wide (0.37 – 2.31).”

Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025

More posts featuring Yakup Ergün and Paolo Tarantino.

Breast Cancer cancer EMBER-3 ESMO Breast 2025 OncoDaily Oncology Paolo Tarantino Yakup Ergün
Special Coverage
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients